Baseline characteristics by CPF
| . | Total(n = 1532) . | Normal CPF(n = 591) . | Unilateral rCPF(n = 353) . | Bilateral rCPF(n = 588) . | P . |
|---|---|---|---|---|---|
| Age, median (SD) | 63.9 (18.4) | 59.5 (16.11) | 63.5 (18.39) | 70.6 (19.75) | <.001* |
| Female, n (%)† | 1056 (68.9) | 409 (69.2) | 234 (66.3) | 413 (70.2) | .44 |
| BMI, median (SD) | 28.8 (6.4) | 29.1 (6.26) | 28.5 (6.55) | 28.9 (6.39) | .66 |
| MI, n (%)† | 20 (1.3) | 7 (1.2) | 3 (0.8) | 10 (1.7) | .51 |
| CHF, n (%)† | 44 (2.9) | 10 (1.7) | 11 (3.1) | 23 (3.9) | .07 |
| PAD, n (%)† | 56 (3.7) | 14 (2.4) | 14 (4.0) | 28 (4.8) | .09 |
| Cerebrovascular disease, n (%)† | 45 (2.9) | 14 (2.4) | 11 (3.1) | 20 (3.4) | .56 |
| Atrial fibrillation/flutter, n (%)† | 107 (7.0) | 34 (5.8) | 16 (4.5) | 57 (9.7) | .004 |
| Dementia, n (%)† | 5 (0.3) | 0 (0.0) | 2 (0.6) | 3 (0.5) | .21 |
| Chronic pulmonary disease, n (%)† | 152 (9.9) | 57 (9.6) | 33 (9.3) | 62 (10.5) | .80 |
| Peptic ulcer disease, n (%)† | 7 (0.5) | 2 (0.3) | 0 (0.0) | 5 (0.9) | .15 |
| Diabetes (without organ damage), n (%)† | 152 (9.9) | 47 (8.0) | 32 (9.1) | 73 (12.4) | .03 |
| Diabetes (with organ damage), n (%)† | 21 (1.4) | 7 (1.2) | 4 (1.1) | 10 (1.7) | .68 |
| Hemiplegia, n (%)† | 3 (0.2) | 1 (0.2) | 1 (0.3) | 1 (0.2) | .91 |
| Renal disease, n (%)† | 35 (2.3) | 7 (1.2) | 3 (0.8) | 25 (4.3) | <.001† |
| Liver disease (mild), n (%)† | 16 (1.0) | 12 (2.0) | 3 (0.8) | 1 (0.2) | .006 |
| Liver disease (moderate to severe), n (%)† | 1 (0.1) | 1 (0.2) | 0 (0.0) | 0 (0.0) | .45 |
| Other cancer, n (%)† | 104 (6.8) | 39 (6.6) | 24 (6.8) | 41 (7.0) | .97 |
| Metastatic solid tumor, n (%)† | 16 (1.0) | 5 (0.8) | 1 (0.3) | 10 (1.7) | .01 |
| AIDS, n (%)† | 0 | 0 | 0 | 0 | |
| Rheumatologic disease, n (%)† | 21 (1.4) | 6 (1.0) | 6 (1.7) | 9 (1.5) | .62 |
| CCI | |||||
| Mean (SD) | 1.9 (2.20) | 1.5 (1.91) | 1.8 (1.98) | 2.4 (2.48) | <.001* |
| Median | 1 | 1 | 1 | 2 | |
| Range | 0.0, 15.0 | 0.0, 12.0 | 0.0, 11.0 | 0.0, 15.0 | |
| Follow-up time, y | |||||
| Mean (SD) | 10.9 (6.45) | 10.1 (6.23) | 10.7 (6.40) | 11.8 (6.59) | <.001* |
| Median | 11.7 | 11.2 | 11.1 | 12.8 | |
| Range | 0.0, 22.0 | 0.0, 22.0 | 0.0, 21.9 | 0.0, 22.0 |
| . | Total(n = 1532) . | Normal CPF(n = 591) . | Unilateral rCPF(n = 353) . | Bilateral rCPF(n = 588) . | P . |
|---|---|---|---|---|---|
| Age, median (SD) | 63.9 (18.4) | 59.5 (16.11) | 63.5 (18.39) | 70.6 (19.75) | <.001* |
| Female, n (%)† | 1056 (68.9) | 409 (69.2) | 234 (66.3) | 413 (70.2) | .44 |
| BMI, median (SD) | 28.8 (6.4) | 29.1 (6.26) | 28.5 (6.55) | 28.9 (6.39) | .66 |
| MI, n (%)† | 20 (1.3) | 7 (1.2) | 3 (0.8) | 10 (1.7) | .51 |
| CHF, n (%)† | 44 (2.9) | 10 (1.7) | 11 (3.1) | 23 (3.9) | .07 |
| PAD, n (%)† | 56 (3.7) | 14 (2.4) | 14 (4.0) | 28 (4.8) | .09 |
| Cerebrovascular disease, n (%)† | 45 (2.9) | 14 (2.4) | 11 (3.1) | 20 (3.4) | .56 |
| Atrial fibrillation/flutter, n (%)† | 107 (7.0) | 34 (5.8) | 16 (4.5) | 57 (9.7) | .004 |
| Dementia, n (%)† | 5 (0.3) | 0 (0.0) | 2 (0.6) | 3 (0.5) | .21 |
| Chronic pulmonary disease, n (%)† | 152 (9.9) | 57 (9.6) | 33 (9.3) | 62 (10.5) | .80 |
| Peptic ulcer disease, n (%)† | 7 (0.5) | 2 (0.3) | 0 (0.0) | 5 (0.9) | .15 |
| Diabetes (without organ damage), n (%)† | 152 (9.9) | 47 (8.0) | 32 (9.1) | 73 (12.4) | .03 |
| Diabetes (with organ damage), n (%)† | 21 (1.4) | 7 (1.2) | 4 (1.1) | 10 (1.7) | .68 |
| Hemiplegia, n (%)† | 3 (0.2) | 1 (0.2) | 1 (0.3) | 1 (0.2) | .91 |
| Renal disease, n (%)† | 35 (2.3) | 7 (1.2) | 3 (0.8) | 25 (4.3) | <.001† |
| Liver disease (mild), n (%)† | 16 (1.0) | 12 (2.0) | 3 (0.8) | 1 (0.2) | .006 |
| Liver disease (moderate to severe), n (%)† | 1 (0.1) | 1 (0.2) | 0 (0.0) | 0 (0.0) | .45 |
| Other cancer, n (%)† | 104 (6.8) | 39 (6.6) | 24 (6.8) | 41 (7.0) | .97 |
| Metastatic solid tumor, n (%)† | 16 (1.0) | 5 (0.8) | 1 (0.3) | 10 (1.7) | .01 |
| AIDS, n (%)† | 0 | 0 | 0 | 0 | |
| Rheumatologic disease, n (%)† | 21 (1.4) | 6 (1.0) | 6 (1.7) | 9 (1.5) | .62 |
| CCI | |||||
| Mean (SD) | 1.9 (2.20) | 1.5 (1.91) | 1.8 (1.98) | 2.4 (2.48) | <.001* |
| Median | 1 | 1 | 1 | 2 | |
| Range | 0.0, 15.0 | 0.0, 12.0 | 0.0, 11.0 | 0.0, 15.0 | |
| Follow-up time, y | |||||
| Mean (SD) | 10.9 (6.45) | 10.1 (6.23) | 10.7 (6.40) | 11.8 (6.59) | <.001* |
| Median | 11.7 | 11.2 | 11.1 | 12.8 | |
| Range | 0.0, 22.0 | 0.0, 22.0 | 0.0, 21.9 | 0.0, 22.0 |